title: Bell's palsy.
abstract: BACKGROUND
  Bell's palsy is characterised by an acute, unilateral, partial, or complete paralysis of the face (i.e., lower motor neurone pattern). The weakness may be partial (paresis) or complete (paralysis), and may be associated with mild pain, numbness, increased sensitivity to sound, and altered taste. Bell's palsy remains idiopathic, but a proportion of cases may be caused by reactivation of herpes viruses from the geniculate ganglion of the facial nerve. Bell's palsy is most common in people aged 15 to 40 years, with a 1 in 60 lifetime risk. Most make a spontaneous recovery within 1 month, but up to 30% show delayed or incomplete recovery.
  
  
  METHODS
  We conducted a systematic review to answer the following clinical question: What are the effects of treatments in adults and children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2010 (Clinical Evidence reviews are updated periodically. Please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
  
  
  RESULTS
  We found 14 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
  
  
  CONCLUSIONS
  In this systematic review we present information relating to the effectiveness and safety of the following interventions: antiviral treatment, corticosteroids (alone or plus antiviral treatment), hyperbaric oxygen therapy, facial nerve decompression surgery, and facial retraining.
authors.affiliation: St Michael's Hospital, University Hospitals Bristol (NHS) Trust, Bristol, UK.
authors.forename: Julian
authors.initials: J
authors.lastname: Holland
authors.forename: Jonathan
authors.initials: J
authors.lastname: Bernstein
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage; D020330:Bell Palsy / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005154:Facial Nerve; D005158:Facial Paralysis / Q000188:drug therapy; D006801:Humans; D015994:Incidence
chemical_list: D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents